Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication

A concomitant drug-based score was developed by our group and externally validated for prognostic and predictive purposes in patients with advanced cancer treated with immune checkpoint inhibitors (ICIs). The model considers the use of three classes of drugs within a month before initiating ICI, ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Buti, Sebastiano, Basso, Umberto, Giannarelli, Diana, De Giorgi, Ugo, Maruzzo, Marco, Iacovelli, Roberto, Galli, Luca, Porta, Camillo, Carrozza, Francesco, Procopio, Giuseppe, Fonarini, Giuseppe, Lo Re, Giovanni, Santoni, Matteo, Sabbatini, Roberto, Cusmai, Antonio, Zucali, Paolo Andrea, Aschele, Carlo, Baldini, Editta, Zafarana, Elena, Favaretto, Adolfo, Leo, Silvana, Hamzaj, Alketa, Mirabelli, Rosanna, Nole’, Franco, Zai, Silvia, Chini, Claudio, Masini, Cristina, Fatigoni, Sonia, Rocchi, Andrea, Tamburini, Emiliano, Cortellini, Alessio, Bersanelli, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561686/
https://www.ncbi.nlm.nih.gov/pubmed/36472582
http://dx.doi.org/10.1097/CJI.0000000000000446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561686/
https://www.ncbi.nlm.nih.gov/pubmed/36472582
http://dx.doi.org/10.1097/CJI.0000000000000446

Ejemplares similares